ScholarX

Journal of Clinical Oncology

Journal Title

  • Journal of Clinical Oncology

ISSN

  • E 1527-7755 | P 0732-183X

Publisher

  • American Society of Clinical Oncology

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • USA

Aime & Scopes

  • JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Homepage

Article List

41 - 60 out of 1,009 results.

SCIESCOPUS
Oregovomab and non-platinum chemotherapy in PARP inhibitor-resistant ovarian, fallopian tube, or primary peritoneal cancer patients not candidates for platinum retreatment: A multicenter, two-cohort, single-arm phase 2 trial (OPERA/KGOG 3065/APGOT-OV6)

Lee, JY[Lee, Jung-Yun]; Park, J[Park, Junsik]; Choi, CH[Choi, Chel Hun]; Cho, HW[Cho, Hyun Woong]; No, JH[No, Jae Hong]; Hong, DG[Hong, Dae Gy]

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Whole genome sequencing for more accurate TMB and mutational signatures in common cancers

Lee, WC[Lee, Won-Chul]; Lim, J[Lim, Joonoh]; Park, S[Park, Seongyeol]; Kim, R[Kim, Ryul]; Oh, BL[Oh, Baek-Lok]; Lee, S[Lee, Sangmoon]; Lee, JS[Lee, Jeong Seok]; Kwon, M[Kwon, Minsuk]; Connolly-Strong, E[Connolly-Strong, Erin]; Hong, SK[Hong, Suk Kyun], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Deep learning-based ensemble model using hematoxylin and eosin (H&E) whole slide images (WSIs) for the prediction of MET mutations in non-small cell lung cancer (NSCLC)

Choi, YL[Choi, Yoon-La]; Park, S[Park, Sehhoon]; Jung, HA[Jung, Hyun Ae]; Sun, JM[Sun, Jong-Mu]; Lee, SH[Lee, Se-Hoon]; Ahn, JS[Ahn, Jin Seok]; Ahn, MJ[Ahn, Myung-Ju]; Lee, T[Lee, Taebum]; Shin, S[Shin, Seunghwan]; Park, J[Park, Jongchan], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A phase II trial of neoadjuvant nivolumab, docetaxel, and cisplatin therapy followed by surgery and radiation therapy for resectable high-grade salivary gland carcinoma

Park, S[Park, Sehhoon]; Kim, EH[Kim, Eun-Hye]; Choi, N[Choi, Nayeon]; Cho, J[Cho, Junhun]; Jung, HA[Jung, Hyun Ae]; Oh, D[Oh, Dongryul]; Lee, SH[Lee, Se-Hoon]; Ahn, YC[Ahn, Yong Chan]; Jeong, HS[Jeong, Han-Sin]; Ahn, MJ[Ahn, Myung-Ju]

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Clinical trial versus standard of care in EGFR-wild type and ALK- negative lung adenocarcinoma: A propensity-matched analysis

Jung, HA[Jung, Hyun Ae]; Park, B[Park, Boram]; Park, S[Park, Sehhoon]; Sun, JM[Sun, Jong-Mu]; Lee, SH[Lee, Se-Hoon]; Ahn, JS[Ahn, Jin Seok]; Ahn, MJ[Ahn, Myung-Ju]

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Six-year safety and efficacy results from the CHRONOS-1 study of the PI3K inhibitor copanlisib in patients with relapsed or refractory follicular lymphoma

Dreyling, MH[Dreyling, Martin H.]; Santoro, A[Santoro, Armando]; Leppa, S[Leppa, Sirpa]; Demeter, J[Demeter, Judit]; Follows, G[Follows, George]; Lenz, G[Lenz, Georg]; Kim, WS[Kim, Won Seog]; Mollica, L[Mollica, Luigina]; Nagler, A[Nagler, Arnon]; Diong, CP[Diong, Colin Phipps], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
SUNMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab in combination with polatuzumab vedotin vs rituximab plus gemcitabine and oxaliplatin in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.

Westin, J[Westin, Jason]; Olszewski, AJ[Olszewski, Adam J.]; Fogliatto, L[Fogliatto, Laura]; Kim, WS[Kim, Won Seog]; Shin, HJ[Shin, Ho-Jin]; Jeon, YW[Jeon, Young-Woo]; Norasetthada, L[Norasetthada, Lalita]; Pavlovsky, A[Pavlovsky, Astrid]; Rego, E[Rego, Eduardo]; Wu, H[Wu, Hao], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Quality of life (QoL) in patients with recurrent ovarian clear cell carcinoma (rOCCC) receiving durvalumab (D) versus physician's choice chemotherapy (PCC) in the randomized phase II MOCCA/APGOT-OV2/GCGS-OV3 trial.

Ngoi, NYL[Ngoi, Natalie Y. L.]; Sun, HY[Sun, Haoyang]; Choi, CH[Choi, Chel Hun]; Heong, V[Heong, Valerie]; Ow, SGW[Ow, Samuel Guan Wei]; Chay, WY[Chay, Wen Yee]; Kim, HS[Kim, Hee Seung]; Goss, G[Goss, Geraldine]; Goh, JC[Goh, Jeffrey C.]; Lin, MQ[Lin, Meiqi], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Zilovertamab vedotin (MK 2140) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Early results from the phase 2 waveLINE-004 study.

Ozcan, M[Ozcan, Muhit]; Lee, ST[Lee, Seung Tae]; Mensah, F[Mensah, Felix]; Modi, D[Modi, Dipenkumar]; Fossa, A[Fossa, Alexander]; Kim, WS[Kim, Won Seog]; Paszkiewicz-Kozik, E[Paszkiewicz-Kozik, Ewa]; Sawalha, Y[Sawalha, Yazeed]; Sevindik, OG[Sevindik, Omur Gokmen]; Norasetthada, L[Norasetthada, Lalita], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
ABN401 in patients with NSCLC with MET exon 14 (METex14) skipping: Result from the pilot expansion study

Lee, DH[Lee, Dae Ho]; Han, JY[Han, Ji-Youn]; Lemech, CR[Lemech, Charlotte Rose]; Millward, M[Millward, Michael]; Roohullah, A[Roohullah, Aflah]; Choi, JY[Choi, Jun Young]; Park, KE[Park, Kyung Eui]; Kim, NY[Kim, Na Young]; Im, S[Im, Sunyhe]; Rajasekaran, N[Rajasekaran, Nirmal], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Clinical outcomes of extramammary Paget's disease in Korea: A multicenter, retrospective study

Sohn, BS[Sohn, Byeong Seok]; Kim, JE[Kim, Jeong Eun]; Kim, M[Kim, Miso]; Hong, JY[Hong, Jung Yong]; Lee, J[Lee, Jieun]; Park, SE[Park, Song Ee]; Kim, H[Kim, Hyojeong]; Lee, HJ[Lee, Hyo Jin]; Kang, EJ[Kang, Eun Joo]; Lee, SI[Lee, Soon Il], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
BOLD-100-001 (TRIO039): A phase 1b/2a study of BOLD-100 in combination with FOLFOX chemotherapy in patients with pre-treated advanced gastric and biliary tract cancer: Efficacy and safety analysis

O'Kane, GM[O'Kane, Grainne M.]; Spratlin, JL[Spratlin, Jennifer L.]; Oh, DY[Oh, Do-Youn]; Rha, SY[Rha, Sun Young]; Elimova, E[Elimova, Elena]; Kavan, P[Kavan, Petr]; Choi, MK[Choi, Moon Ki]; Goodwin, RA[Goodwin, Rachel Anne]; Kim, ST[Kim, Seung Tae]; Koo, DH[Koo, Dong-Hoe], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Integrated efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK plus NSCLC in the ALTA-1L and J-ALTA studies

Camidge, DR[Camidge, D. Ross]; Sugawara, S[Sugawara, Shunichi]; Kondo, M[Kondo, Masashi]; Kim, HR[Kim, Hye Ryun]; Ahn, MJ[Ahn, Myung-Ju]; Yang, JCH[Yang, James Chih-Hsin]; Han, JY[Han, Ji-Youn]; Hochmair, MJ[Hochmair, Maximilian J.]; Lee, KH[Lee, Ki Hyeong]; Delmonte, A[Delmonte, Angelo], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Neoadjuvant giredestrant plus palbociclib (P) vs. anastrozole (A) plus P in postmenopausal women with estrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+, HER2-eBC): Patient (pt)-reported outcomes (PROs) in the randomized, open-label, international phase II coopERA BC study

Park, YH[Park, Yeon Hee]; Quiroga, V[Quiroga, Vanesa]; Fasching, PA[Fasching, Peter A.]; Bardia, A[Bardia, Aditya]; Lopez-Valverde, V[Lopez-Valverde, Vanesa]; Crnjevic, TB[Crnjevic, Tanja Badovinac]; Steinseifer, J[Steinseifer, Jutta]; Devine, J[Devine, Jacob]; Hurvitz, SA[Hurvitz, Sara A.]

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
First results from the RedirecTT-1 study with teclistamab (tec) plus talquetamab (tal) simultaneously targeting BCMA and GPRC5D in patients (pts) with relapsed/refractory multiple myeloma (RRMM)

Cohen, YC[Cohen, Yael C.]; Morillo, D[Morillo, Daniel]; Gatt, ME[Gatt, Moshe E.]; Sebag, M[Sebag, Michael]; Kim, K[Kim, Kihyun]; Min, CK[Min, Chang-Ki]; Oriol, A[Oriol, Albert]; Ocio, EM[Ocio, Enrique M.]; Yoon, SS[Yoon, Sung-Soo]; Mateos, MV[Mateos, Maria-Victoria], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
EGRET: A first-in-human study of the novel antibody-drug conjugate (ADC) AZD9592 as monotherapy or combined with other anticancer agents in patients (pts) with advanced solid tumors

Aggarwal, C[Aggarwal, Charu]; Azzoli, CG[Azzoli, Christopher G.]; Spira, AI[Spira, Alexander I.]; Solomon, BJ[Solomon, Benjamin J.]; Le, XN[Le, Xiuning]; Rolfo, C[Rolfo, Christian]; Planchard, D[Planchard, David]; Felip, E[Felip, Enriqueta]; Wu, YL[Wu, Yi-Long]; Ahn, MJ[Ahn, Myung-Ju], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
STAR-121: A phase 3, randomized study of domvanalimab (DOM) and zimberelimab (ZIM) in combination with chemotherapy vs pembrolizumab (pembro) and chemotherapy in patients with untreated metastatic non-small cell lung cancer (mNSCLC) with no actionable gene alterations.

Rodriguez-Abreu, D[Rodriguez-Abreu, Delvys]; Gray, JE[Elaine Gray, Jhanelle]; Ahn, MJ[Ahn, Myung-Ju]; Johnson, ML[Lynne Johnson, Melissa]; Yu, XW[Yu, Xinwei]; Chen, XY[Chen, Xueying]; Phuong, PH[Hoang Phuong, Patrick]; Kim, J[Kim, Jongseok]; Reck, M[Reck, Martin]

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Artificial intelligence (AI) -powered spatial analysis of tumor-infiltrating lymphocytes (TILs) for prediction of prognosis in resectable pancreatic adenocarcinoma (PDAC)

Lim, Y[Lim, Yoojoo]; Choi, JH[Choi, Jin Ho]; Kim, H[Kim, Hyemin]; Han, IW[Han, In Woong]; Song, S[Song, Sanghoon]; Shin, J[Shin, Jiwon]; Song, H[Song, Heon]; Park, S[Park, Seonwook]; Pereira, S[Pereira, Sergio]; Shin, SH[Shin, Sang Hyun], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Whole-genome sequencing based assessment of HER2 focal amplification for precision oncology of breast cancers

Kim, R[Kim, Ryul]; Lim, J[Lim, Joonoh]; Park, H[Park, Hansol]; Park, S[Park, Seongyeol]; Oh, BL[Oh, Baek-Lok]; Lee, S[Lee, Sangmoon]; Kim, JY[Kim, Ji-Yeon]; Nam, SJ[Nam, Seok Jin]; Kim, SW[Kim, Seok Won]; Lee, JE[Lee, Jeong Eon], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Immune checkpoint inhibitors use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B

Hong, J[Hong, Joohyun]; Lee, J[Lee, Jiyun]; Park, S[Park, Sehhoon]; Jung, HA[Jung, Hyun Ae]; Sun, JM[Sun, Jong-Mu]; Lee, SH[Lee, Se-Hoon]; Ahn, JS[Ahn, Jin Seok]; Sinn, DH[Sinn, Dong Hyun]; Ahn, MJ[Ahn, Myung-Ju]

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
1 2 3 4 5 6 7 8 9 10 last
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어